Brief: GeneOne Life, Inovio Pharma expect to move MERS vaccine into Phase I trial before year end

Gene One Life Science

19/10/2015 13:03

Oct 19 (Reuters) - GeneOne Life Science Inc  011000.KS : 
 * Announced filing of investigational new drug application (ind) for gls-5300 
   with United States food and drug administration 
 * Co and Inovio Pharmaceuticals expect to move mers vaccine into phase i 
   clinical trial in healthy volunteers before year end 
 * Source text for Eikon  ID:nGNXMCXHEa  
 * Further company coverage  011000.KS  
 
 ((Bengaluru Newsroom; +1 646 223 8780))